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aBstraCt
introduCtion. The aim of this study is to identify the visual outcome and possible complications of partial tran-
sepithelial topography-guided PRK combined with collagen crosslinking in patients with keratoconus.
MateriaLs and Methods. Twenty eyes (20 patients) were treated with partial transepithelial topography-guided 
PRK combined with collagen crosslinking. Patients were evaluated preoperatively for best spectacle corrected visual 
acuity (BSCVA), clinical signs of keratoconus via slit lamp examination, and Scheimpflug-generated corneal topo-
graphy. All eyes were treated with Amaris 750s Excimer Laser and KXL system.
resuLts. Mean BCVA was improved from 20/100 to 20/25, postoperatively. Mean flat K was 46.8 ± 0.14 D 
preoperatively and was reduced to 45.2 ± 0.7 D postoperatively. Mean steep K was reduced from 50.2 ± 0.10 D 
to 47 ± 0.6 D. Total corneal astigmatism was 4.5 ± 0.14 D and decreased to 2.5 ± 0.10 D postoperatively. Average 
thinnest pachymetry was reduced from 465 ± 9.9 μm to 416 ± 11.3 μm. Total RMS (corneal aberrations) was 
15.5 ± 7.4μm and was significantly reduced to 5.5 ± 2 μm.
ConCLusions. Partial transepithelial topography-guided PRK combined with collagen crosslinking can benefit 
patients fitting the criteria for such a procedure, by stabilising their cornea as well as improving their BSCVA.
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introduCtion
Keratoconus is a corneal abnormality [1] where 
the central or paracentral cornea undergoes pro-
gressive thinning and steepening, causing irregular 
astigmatism. Its aetiology is unknown, but there 
are some systemic diseases associated with the 
appearance of keratoconus such as Down’s syn-
drome, Marfan’s syndrome, and Ehler’s Danlos 
connective disorders. Keratoconus diagnosis can 
be achieved thorough slit lamp examination and 
observation of central or inferior corneal thin-
ning, and also with corneal topography. Some 
early signs [2, 3] of keratoconus are asymmetric 
refractive error with high or progressive astigma-
tism, keratometry showing high astigmatism and 
irregularity, scissoring of the red reflex on retinos-
copy, and inferior steepening. The vast majority 
of keratoconus patients can be visually rehabili-
tated with glasses or rigid gas permeable lenses [4] 
(RGPs). In only a small percentage of keratoconus 
patients is a cornea transplant needed. The use of 
RGP contact lenses cannot stop the progression of 
the disease. However, some patients have contact 
lens intolerance [5] and their best spectacle cor-
rected visual acuity with glasses is not sufficient 
for giving them a good quality of life. 
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More than 10 years ago corneal collagen 
crosslinking (riboflavin and ultraviolet light) was 
proposed as a therapeutic approach [6] by Dr. Seiler 
and his team to improve the biochemical and bio-
mechanical properties of the cornea. There is clinical 
evidence6 that corneal crosslinking is a useful pro-
cedure that stops the progression of keratoconus. 
As a positive side effect some treated eyes presented 
a significant flattening [7] of the cornea (in rare cas-
es the regression was more than 10 dioptres), which 
resulted in visual acuity improvement. In our study 
we analyse the one-year results of transepithelial 
topography-guided partial PRK combined with cor-
neal collagen crosslinking (CXL) in order to identify 
the visual outcome and possible complications of 
this procedure.
MateriaLs and Methods
Twenty patients (20 eyes) were included in the 
study. All participants were diagnosed with grade 
3 keratoconus or above. Preoperatively patients 
received a complete ocular examination by Dr. 
Mallias, including best spectacle corrected visual 
acuity, subjective refraction, and slit lamp exam-
ination for clinical signs of keratoconus. They 
were also monitored with Scheimpflug-gener-
ated corneal topography (Pentacam HR, Ocu-
lus, Germany). Inclusion criteria were definite 
findings of consistent keratoconus, verified with 
consecutive topographies. Exclusion criteria were 
previous corneal surgery, history of chemical in-
jury, delayed epithelial healing, systemic or oth-
er ocular diseases, pregnancy, lactation, and the 
use of oral oestrogen. All patients participating 
in this study had preoperative corneal thickness 
above 400 μm. All surgeries were performed by 
Dr. Mallias, using an Excimer Laser Amaris 750s 
(Schwind, Germany) and KXL System (Avedro, 
USA). Patients were thoroughly screened 1, 6, 
and 12 months postoperatively. In every follow-up 
visit all patients underwent slit lamp examination, 
best spectacle corrected visual acuity (BSCVA) 
measurement, intraocular pressure measurement, 
and corneal topography with Pentacam HR. Pa-
tients using RGPs were asked to stop the usage of 
their contact lenses for at least three weeks before 
the operation and at least one month postopera-
tively. Prior to the operation, all surgical risks were 
explained to patients and informed consent was 
signed by all of them.
surgiCaL teChniQue
The first step of the procedure was a partial 
transepithelial topography-guided PRK performed 
by Amaris 750s and followed by CXL procedure. 
The maximum tissue ablation was limited to 50 mi-
crons of corneal stroma. Riboflavin (Vibex Rapid, 
0.1% Riboflavin, Saline, HPMC, Avedro, USA) 
was instilled onto the cornea every two minutes for 
10 minutes and then rinsed thoroughly. Then UVA 
was applied with the on-off module (UVA is on for 
one second and off for another second in order to 
avoid depletion of oxygen) for eight minutes, and 
the power was 30 mW/cm2.
At the end of the operation a bandage soft con-
tact lens was applied until re-epithelisation was 
achieved (approximately four days postop). Patients 
received ofloxacin four times daily, dexamethasone 
four times daily, and preservative-free artificial tears 
every two hours. After complete healing of the 
corneal epithelium, the bandage contact lens was 
removed and patients were given preservative-free 
artificial tears and Loteprednol drops three times 
daily slowly tapered over a period of one month.
resuLts
From the 20 patients (20 eyes) 13 were female 
and 7 were male. The mean age of the patients was 
26.4 ± 4 years. Their mean preoperative BSCVA was 
20/100, and mean postoperative BSCVA at the end 
of the one-year follow-up period was 20/25. The 
preoperative mean flat K was 46.8 ± 0.14 D, and 
it was reduced to 45.2 ± 0.7 D. The preoperative 
mean steep K showed significant reduction from 
50.2 ± 0.10 D to 47 ± 0.6 D. The total corneal 
astigmatism was 4.5 ± 0.14 D preoperatively and 
2.5 ± 0.10 D postoperatively. The average thinnest 
pachymetry was reduced from 465 ± 9.9 μm to 
416 ± 11.3 μm postoperatively. Total RMS (corneal 
aberrations) was 15.5 ± 7.4μm and was significantly 
reduced to 5.5 ± 2 μm. We believe that this reduc-
tion is very important because it improves the image 
quality of the patient (Fig. 1).
There were no complications after the operation 
in any of the patients besides some mild haze, which 
was not visually significant and was managed with 
prolonged use of steroid drops (Fig. 2).
As can be seen in Image 1 and 2, the flattening of 
the cornea after transepithelial topography-guided par-
tial PRK combined with corneal collagen crosslinking 
is obvious and the keratoconic indices are much lower. 
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disCussion
As shown above, transepithelial topogra-
phy-guided partial PRK combined with corneal col-
lagen crosslinking can be a good option that offers 
cornea stabilisation as well as BSCVA improvement 
in patients who satisfy the criteria to proceed in 
such a surgery. Patients included in this study were 
classified as grade 3 keratoconus or above and their 
visual acuity was below 20/40. The reason is that 
if keratoconus is not that advanced or BSCVA is 
better, there is no need to proceed in a combined 
surgery since CXL standalone has shown corneal 
stabilisation and, as mentioned before, in some cases 
even corneal flattening. What should be mentioned 
is that the maximum ablation in this procedure is 
low, because its goal is not to eliminate refractive 
error but to “normalise” the cornea as much as pos-
sible. Also the on-off technique in corneal collagen 
crosslinking was employed to avoid the depletion 
of oxygen, which is needed for the creation of cross 
links in corneal collagen fibres.
There are other studies [8, 9] also dealing with 
excimer laser ablation combined with collagen 
crosslinking in keratoconic and ectatic eyes. In some 
studies the minimum corneal thickness was less than 
400 μm. We believe that if the preoperative central 
corneal thickness (CCT) is bellow 400 μm, there is 
a possibility of toxicity in endothelial cells. Patients 
with advanced keratoconus and very thin corneas 
(CCT < 350 μm) are not good candidates for such 
the procedure described in this paper. We believe 
that these patients should proceed with a corneal 
transplant for better visual results. The main goal 
of such a combined procedure is to stabilise the 
cornea as well as to improve the BSCVA for patients 
who have contact lens intolerance due to allergic 
conjunctivitis [10], to avoid corneal transplant. 
Nevertheless, a study should be conducted to com-
pare CXL standalone results with those undergoing 
a combined surgery, in order to determine whether 
or not CXL standalone can provide efficient corneal 
flattening. 
As can be seen in Figure 3, in order to normalise 
the corneal surface, a mild ablation occurs on the 
cone and there is ablation of corneal tissue at the 
periphery of the cornea. Any ablation at the corneal 
periphery is a hyperopic ablation, and this explains 
our finding that there was a slight increase in my-
opia in all of these patients. This is the “price” that 
patients had to pay, in order to achieve regularisa-
tion of the anterior corneal surface and improve-
ment of BSCVA. 
We observed a significant reduction of RMS 
(corneal aberrations) calculated by Pentacam HR, 
postoperatively. Such a reduction as shown in the 
results above, indicates not only that BSCVA was 
improved, but aberrations naturally existing in kera-
toconic corneas were reduced, resulting in improve-
ment in the quality of the image as well. To our 
knowledge, this is the first paper discussing RMS 
Figure 1. Preoperative and postoperative topography of a patient who underwent topography-guided partial PRK combined with corneal 
collagen crosslinking, and a comparison of them
Figure 2. Same patient as in Figure 1 pre- and postoperative to-
pometric indices showing great improvement of corneal irregularity
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(corneal aberrations) in keratoconus eyes before af-
ter excimer laser ablation combined with CXL.
We know that due to CXL there is apoptosis [11] 
of keratocytes from the anterior stroma. Because 
of the apoptosis, keratocytes do not produce the 
extracellular substance that is responsible for the 
development of corneal haze. This is the main rea-
son we did not use mitomycin C in transepithelial 
topography-guided partial PRK combined with cor-
neal collagen crosslinking cases, even if some similar 
studies [12] widely use it in order to avoid haze. 
Another reason not to use mitomycin if it is not 
really necessary is the possible complications caused 
by its use [13]. What should be noted is that a large 
study should be conducted in order to investigate 
whether or not the use of Mitomycin reduces the 
possibility of haze appearance in such combined 
procedures with corneal crosslinking.
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Figure 3. Ablation profile
